The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia

被引:0
|
作者
Morabito, Fortunato [1 ]
Tripepi, Giovanni [2 ]
Mauro, Francesca Romana [3 ]
Laurenti, Luca [4 ]
Reda, Gianluigi [5 ,6 ]
Moia, Riccardo [7 ]
Condoluci, Adalgisa [8 ,9 ]
Vincelli, Iolanda [10 ]
Chiarenza, Annalisa [11 ]
Vigna, Ernesto [12 ]
Martino, Enrica Antonia [12 ]
Bruzzese, Antonella
Mezzatesta, Sabrina [2 ]
Laureana, Roberta [13 ]
Cutrona, Giovanna [14 ]
Di Raimondo, Francesco
Fronza, Gilberto [15 ]
Zucchetto, Antonella [16 ]
Bomben, Riccardo [16 ]
Rossi, Francesca Maria [16 ]
Olivieri, Jacopo [17 ]
Zaja, Francesco [18 ]
Rossi, Davide [8 ,9 ]
Gaidano, Gianluca [7 ]
Del Principe, Maria Ilaria [13 ]
Ilariucci, Fiorella [19 ]
Del Poeta, Giovanni [13 ]
Ferrarini, Manlio [14 ]
Neri, Antonino [20 ]
Gattei, Valter [16 ]
Gentile, Massimo [12 ,21 ]
机构
[1] AO ASP Cosenza, Biotechnol Res Unit, Aprigliano, I-87100 Cosenza, Italy
[2] CNR, Ist Fisiol Clin CNR, Reggio Di Calabria, Italy
[3] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy
[4] Catholic Univ Hosp A Gemelli Rome, Dept Hematol, Rome, Italy
[5] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol CTMO, Milan, Italy
[7] Univ Piemonte Orientale, Dept Translat Med, Div Haematol, Novara, Italy
[8] Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[9] Inst Oncol Res, Bellinzona, Switzerland
[10] Hematol Unit Reggio Calabria, Reggio Di Calabria, Italy
[11] Univ Catania, Osped Ferrarotto, Div Ematol, Catania, Italy
[12] AO Cosenza, Dept Oncohematol, Hematol Unit, Cosenza, Italy
[13] Univ Roma Tor Vergata, Dipartimento Biomed & Prevenz, Ematol, Rome, Italy
[14] Osped Policlin San Martino IRCCS, UO Mol Pathol, Genoa, Italy
[15] IRCCS Osped Policlin San Martino, Mutagenesis & Canc Prevent Unit, Genoa, Italy
[16] Ctr Riferimento Oncol Aviano CRO IRCCS, Clin & Expt Onco Hematol Unit, Aviano, Italy
[17] Azienda Osped Univ S Maria Misericordia, Ctr Trapianti & Terapie Cellulari, Clin Ematol, Udine, Italy
[18] Univ Trieste, Haematol, Trieste, Italy
[19] Azienda USL IRCCS Reggio Emilia, Hematol Unit, Reggio Emilia, Italy
[20] Azienda USL IRCCS Reggio Emilia, Sci Directorate, Reggio Emilia, Italy
[21] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy
基金
瑞士国家科学基金会; 欧洲研究理事会;
关键词
PROGRESSION; RISK;
D O I
10.1002/ajh.26927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E157 / E160
页数:4
相关论文
共 50 条
  • [21] Percentage of smudge cells on routine blood smears predict time to first treatment and overall survival in patients with Binet stage A chronic lymphocytic leukemia
    Johansson, P.
    Nueckel, H.
    Duehrsen, U.
    Duerig, J.
    ONKOLOGIE, 2011, 34 : 139 - 139
  • [22] Association of Clonal Hematopoiesis of Indeterminate Potential with Time to First Treatment, Incidence of Richter's Syndrome, and Overall Survival in Patients with Chronic Lymphocytic Leukemia
    Vijenthira, Abi
    Sekar, Aswin
    Gibson, Christopher J.
    Martindale, Stephen P.
    Fardoun, Rayan
    Tyekucheva, Svitlana
    Ren, Yue
    Fernandes, Stacey M.
    Knisbacher, Binyamin A.
    Hahn, Cynthia K.
    Getz, Gad
    Wu, Catherine J.
    Davids, Matthew S.
    Brown, Jennifer R.
    BLOOD, 2022, 140 : 9868 - 9870
  • [23] Association between hypertension and overall survival in chronic lymphocytic leukemia
    Vainer, Noomi
    Brieghel, Christian
    Hjalgrim, Henrik
    Niemann, Carsten
    Rotbain, Emelie Hamotal Curovic
    LEUKEMIA & LYMPHOMA, 2023, 64 : S22 - S23
  • [24] Predicting Time to First Treatment in Chronic Lymphocytic Leukemia using Machine Learning Survival and Classification Methods
    Chen, David
    Goyal, Gaurav
    Go, Ronald
    Parikh, Sameer
    Ngufor, Che
    2018 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI), 2018, : 407 - 408
  • [25] Early progression of disease as a predictor of survival in chronic lymphocytic leukemia
    Ahn, Inhye E.
    Farber, Charles M.
    Davids, Matthew S.
    Grinblatt, David L.
    Kay, Neil E.
    Lamanna, Nicole
    Mato, Anthony
    Nabhan, Chadi
    Kiselev, Pavel
    Swern, Arlene S.
    Flick, E. Dawn
    Sullivan, Kristen
    Sharman, Jeff P.
    Flowers, Christopher R.
    BLOOD ADVANCES, 2017, 1 (25) : 2433 - 2443
  • [26] Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia
    Wierda, William G.
    O'Brien, Susan
    Wang, Xuemei
    Faderl, Stefan
    Ferrajoli, Alessandra
    Do, Kim-Anh
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Thomas, Deborah
    Koller, Charles A.
    Burger, Jan A.
    Lerner, Susan
    Schlette, Ellen
    Abruzzo, Lynne
    Kantarjian, Hagop M.
    Keating, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4088 - 4095
  • [27] mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients
    Kontos, Christos K.
    Adamopoulos, Panagiotis G.
    Papageorgiou, Sotirios G.
    Pappa, Vassiliki
    Scorilas, Andreas
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (02) : 315 - 324
  • [28] MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia
    Papageorgiou, Sotirios G.
    Diamantopoulos, Marios A.
    Kontos, Christos K.
    Bouchla, Anthi
    Vasilatou, Diamantina
    Bazani, Efthymia
    Scorilas, Andreas
    Pappa, Vasiliki
    LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 658 - 667
  • [29] Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia
    Visentin, Andrea
    Facco, Monica
    Frezzato, Federica
    Castelli, Monica
    Trimarco, Valentina
    Martini, Veronica
    Gattazzo, Cristina
    Severin, Filippo
    Chiodin, Giorgia
    Martines, Annalisa
    Bonaldi, Laura
    Gianesello, Ilaria
    Pagnin, Elisa
    Boscaro, Elisa
    Piazza, Francesco
    Zambello, Renato
    Semenzato, Gianpietro
    Trentin, Livio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (10): : 612 - 620
  • [30] EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL
    Carli, G.
    Visco, C.
    Falisi, E.
    Perbellini, O.
    Pascarella, M.
    Rossi, D.
    Novella, E.
    Giaretta, I.
    Cavallini, C.
    Scupoli, M. T.
    De Rossi, A.
    D'Amore, E. S.
    Rassu, M.
    Gaidano, G.
    Pizzolo, G.
    Ambrosetti, A.
    Rodeghiero, F.
    HAEMATOLOGICA, 2015, 100 : 76 - 77